Overview
Lung cancer is one of the leading causes of cancer death worldwide, but outcomes have improved dramatically with molecular testing and targeted drugs. Non-small cell lung cancer (NSCLC) makes up about 85% of cases and often carries actionable mutations like EGFR, ALK or ROS1.
Dr. Ravi Jaiswal offers full biomarker testing and personalised treatment — from oral targeted pills to immunotherapy and combination chemotherapy — tailored to your tumour profile.
Symptoms to watch for
- Persistent cough that worsens over time
- Coughing up blood or rust-coloured sputum
- Chest pain that worsens with deep breathing
- Unexplained weight loss and fatigue
- Shortness of breath or recurrent chest infections
How we treat it
- Molecular testing (EGFR, ALK, ROS1, PD-L1) to guide therapy
- Oral targeted therapies (osimertinib, alectinib, others)
- Immunotherapy (pembrolizumab, nivolumab)
- Platinum-based chemotherapy for advanced disease
- Maintenance therapy to prolong remission
Frequently asked questions
I don't smoke — can I still get lung cancer?+
Yes. About 15–20% of lung cancers in India occur in non-smokers, often driven by genetic mutations that respond well to targeted therapy.
How is stage 4 lung cancer treated today?+
Stage 4 lung cancer is now often a chronic disease. Targeted therapies and immunotherapy can control it for years with a good quality of life.
This page is for information only and does not replace a medical consultation. Please speak to a qualified doctor for advice specific to your condition.